Nov 12, 2021 | Comparative Effectiveness, Cost Savings, Generic Drugs, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Savings, Specialty Drugs
MedBen Rx comparative effectiveness brings clinical research and employers together to find the most effective drugs at the best cost. You can save 10-40% on pharmacy costs by changing to drugs with better outcomes. The benefits of comparative effectiveness include:...
Jun 14, 2021 | Brand Name Drugs, Comparative Effectiveness, Cost Savings, MedBen Rx, Prescription, Rx Costs, Specialty Drugs
The prices of 260 popular brand-name prescription drugs rose 3% from 2019 to 2020 – twice as much as the 1.3% rate of inflation during the same period, according to a new AARP report. Their analysis also found that over the past 15 years, prices of 65 common brands...
Jan 10, 2021 | Brand Name Drugs, Cost Savings, Generic Drugs, Prescription, Rx Costs, Savings, Specialty Drugs
GoodRx has compiled a list of drugs that saw manufacturer price increases in January 2021. In total, 589 drugs – all but seven of them brand-name medications  – increased in price, by an average of 4.2%. Among the better known brand-name drugs on the list are Humira...
Sep 18, 2020 | Cost Savings, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Rebates, Rx Costs, Specialty Drugs, Transparency
Employers could save billion of dollars every year by avoiding “wasteful drugs,” according to BenefitsPro. Guidelines from Pacific Business Group on Health and and researchers from Johns Hopkins University identified 49 high-price medications with less...
Feb 17, 2020 | Affordable Care Act, Announcements, Compliance, Health Care Reform, Specialty Drugs, USPSTF
Per the Affordable Care Act (ACA), employer-sponsored health plans will be required to cover the HIV specialty drugs Pruvada and Descovy at 100% beginning their first plan year following June 19, 2020. The requirement follows a United States Preventive Services Task...
Feb 23, 2019 | Cost Savings, MedBen Rx, Prescription, Rebates, Specialty Drugs, Transparency
A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it’s why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer costs. As...
